Park National Corp’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,450
Closed -$227K 339
2019
Q2
$227K Sell
2,450
-260
-10% -$24.7K 0.01% 291
2019
Q1
$256K Buy
+2,710
New +$237K 0.01% 272
2018
Q2
Sell
-2,596
Closed -$232K 367
2018
Q1
$232K Sell
2,596
-1,479
-36% -$142K 0.01% 310
2017
Q4
$425K Sell
4,075
-50
-1% -$5.64K 0.02% 225
2017
Q3
$601K Buy
4,125
+426
+12% +$58K 0.03% 189
2017
Q2
$481K Sell
3,699
-53
-1% -$6.49K 0.03% 203
2017
Q1
$467K Buy
3,752
+684
+22% +$81.9K 0.03% 211
2016
Q4
$355K Sell
3,068
-90
-3% -$10K 0.02% 229
2016
Q3
$330K Buy
3,158
+12
+0.4% +$1.3K 0.02% 236
2016
Q2
$310K Sell
3,146
-85
-3% -$8.79K 0.02% 249
2016
Q1
$324K Buy
3,231
+426
+15% +$43.9K 0.02% 238
2015
Q4
$336K Buy
2,805
+819
+41% +$94.8K 0.02% 228
2015
Q3
$215K Buy
+1,986
New +$246K 0.02% 279
2015
Q2
Sell
-1,800
Closed -$208K 344
2015
Q1
$208K Sell
1,800
-5,084
-74% -$608K 0.01% 308
2014
Q4
$770K Hold
6,884
0.05% 157
2014
Q3
$652K Sell
6,884
-140
-2% -$12.6K 0.05% 164
2014
Q2
$603K Buy
7,024
+200
+3% +$15.2K 0.04% 173
2014
Q1
$476K Buy
6,824
+306
+5% +$24.2K 0.03% 191
2013
Q4
$551K Hold
6,518
0.04% 175
2013
Q3
$502K Buy
+6,518
New +$457K 0.04% 181

Other funds holding CELG

Park National Corp's CELG Position: Q3 2019 in Review

Park National Corp sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 2,450 shares — an estimated $227K sold.

Park National Corp first reported a position in CELG in Q3 2013 and held it in 20 quarters. The position peaked at $770K in Q4 2014. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Park National Corp reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Park National Corp sold 2,450 Celgene Corp shares in Q3 2019, an estimated $227K.
  • Park National Corp first reported a position in Celgene Corp in Q3 2013 and held it in 20 quarters.
  • Park National Corp's Celgene Corp position peaked at $770K in Q4 2014.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Park National Corp's 13F filing for Q3 2019, filed 1 Oct 2019.